Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases

UNC Libraries(2020)10.17615/5axk-8481Source: DataRank Database

CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: greenTopics (35)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Joyce A. Goldstein,Corina Candiani,Tandrea Hilliard,Joyce Blaisdell,Melanie S. Joy ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4301031806

National Institutes of Health

Grant: 1K23DK064888-01A1

Pharmacokinetics &Genomics in Glomerular Diseases

FWCI

0.00

Citation Percentile

0.4%

greenLicense: Springer TDM

repositoryhttps://doi.org/10.17615/5axk-8481

https://doi.org/10.1007/s00228-009-0707-7

https://europepmc.org/articles/pmc2901912?pdf=render

https://dx.doi.org/10.17615/5axk-8481

https://pubmed.ncbi.nlm.nih.gov/19669737

Fields of Study

Pharmacogenetics and Drug MetabolismElectrolyte and hormonal disordersHormonal Regulation and Hypertension03 medical and health sciences0302 clinical medicine

Keywords

LosartanPharmacodynamicsMedicineGenotypePharmacologyPrimary (astronomy)Internal medicineBiologyReceptorAngiotensin IIPharmacokineticsGeneticsGeneAdultMaleBlood PressureMiddle AgedPolymorphism, Single NucleotideWhite PeopleProteinuriaGene FrequencyHumansKidney Failure, ChronicFemaleAryl Hydrocarbon HydroxylasesAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsAgedCytochrome P-450 CYP2C9Glomerular Filtration Rate

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger